Lippincott ® NursingCenter ® Wolters Kluwer Logo

Olutasidenib as a Breakthrough for R/R mIDH1 AML Patients

Source:

Oncology Times

March 2024, Volume :46 Number 3 , page 33 - 33 [Free]

Go to article

Authors

  1. Kumar Das , Dibash

FIND YOUR NEXT JOB WITH NURSING JOBSPLUS

CE Resources

Nursing Resources

About NursingCenter

 

© 2024 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved. – Terms & Conditions – Privacy Policy – Disclaimer – Your California Privacy Choices -- v09.09.00